# REDOX PHARMACEUTICAL CORP — Form D

REDOX PHARMACEUTICAL CORP of GREENVALE, NY, a company, filed a Form D exempt-offering notice with the SEC on 2010-01-11. The offering totals $2.3M, of which $123K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2010-01-11
- Form: D
- Accession: 0000899341-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.3M
- Amount sold: $123K
- Remaining: $2.2M
- Minimum investment: $200
- Investors: 44
- Date of first sale: 2009-10-18
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-89934-1N

## Issuer

- Name: REDOX PHARMACEUTICAL CORP
- CIK: 0000899341
- Entity type: Corporation
- Jurisdiction: NEW YORK
- Address: 100 FOREST DRIVE, GREENVALE, NY, 11548
- Phone: 516-484-2600 X280

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Donald Brown | Executive Officer | Farmers Branch, TX |

## More

- [CIK 899341 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=899341&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000899341-10-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.